国立結核撲滅プログラム (NTEP) のガイドラインの下で,肺以外の結核患者の診断と治療におけるギャップを評価する:多中心的なコホート研究
Sanjeev Sinha1, Renuka Titiyal1, Prasanta R Mohapatra2
1Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Tropical medicine and infectious disease
|August 27, 2025
まとめ
肺の外結核 (EPTB) の診断と治療は,ガイドラインの偏差による課題に直面しています. 微生物学的検査と医師の訓練の改善は,よりよいEPTB管理に不可欠です.
科学分野:
- 感染症
- 肺科
- 公衆衛生
背景:
- 肺の外結核 (EPTB) は様々な臨床的症状を呈し,診断と治療を複雑にする.
- EPTBの最適な管理は変化し,多くの場合,国家ガイドラインから逸脱し,ケアにおける潜在的なギャップを示しています.
研究 の 目的:
- EPTBの診断と治療に関する国家指針の遵守におけるギャップと障壁を特定する.
- EPTB管理のための患者と医療制度のプロセスの遅延を評価する.
主な方法:
- EPTB患者433人を対象に実施した研究で,追跡調査は2, 6, 9, 12ヶ月に行われました.
- 各部門の医師や患者とのアンケートによるインタビュー
- 臨床放射線学的発見と微生物学的確認による依存を含む診断方法の分析.
主要な成果:
- 微生物学的サポートなしで臨床放射線診断に大きく依存し,国家結核撲滅プログラム (NTEP) のガイドラインから逸脱することが観察されました.
- 4. 2週間 (患者),4週間 (医療システム),10. 1週間 (合計) の中位期間で,患者と医療システムの間に重大な遅れが認められた.
- これらの偏差は,EPTBの誤診と過剰治療の可能性を懸念します.
結論:
- 微生物学的検査へのアクセスの改善は EPTBの正確な診断に不可欠です.
- NTEPのガイドラインに関する医師の訓練を改善し,画像と組織病理学の利用を拡大する必要があります.
- 診断と治療の遅延に対処することは,EPTBの効果的な管理と排除の取り組みにとって極めて重要です.
関連する概念動画
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pneumonia III: Complications and Assessment
432
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
432


